Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-645-1 | CAS number: 536-74-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 17, 2022 to March 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442E (In Vitro Skin Sensitisation: human Cell Line Activation Test (h-CLAT))
- Version / remarks:
- June 25, 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- human Cell Line Activation Test (h-CLAT)
- Justification for non-LLNA method:
- Non-animal testing is the default requirement for skin sensitisation.
Test material
- Reference substance name:
- Phenylacetylene
- EC Number:
- 208-645-1
- EC Name:
- Phenylacetylene
- Cas Number:
- 536-74-3
- Molecular formula:
- C8H6
- IUPAC Name:
- ethynylbenzene
- Test material form:
- liquid
Constituent 1
In vitro test system
- Details of test system:
- THP-1 cell line [442E]
- Details on the study design:
- PRELIMINARY STUDY : Cytotoxicity assays
The cytotoxicity of the test item was evaluated in order to select at least 4-5 concentrations able to induce cytotoxicity, around 50%, for the highest one. Assessment of cell toxicity was performed by determining cell viability on THP-1 cells, using the 7-AAD inclusion methods.
Eight concentrations of test item were prepared by a two-fold serial dilution from a maximum final concentration of 1000 µg/mL or lower, depending on its solubility limit.
In the day of testing, cells harvested from culture flask were suspended with fresh culture medium at 2 x 10^6 cells/mL. Then, THP-1 cells were distributed into a 24 well flat-bottom plate with 500 µL (1 x 10^6 cells/well) with various concentrations of test item (1:1 ratio) for 24±0.5 hours at 37 °C under 5 % CO2. After treatment, cells were transferred into sample tubes and collected by centrifugation. The supernatants were discarded and the remaining cells were resuspended with phosphate-buffered containing 0.1% (w/v) bovine serum albumin identified as Fb .Cells were stained with 7-AAD (5 µg/mL final concentration). Then cells were analysed with flow cytometry using GUAVA (Merck Millipore, France) and InCyte software to measure cell viability. The living cells (7-AAD-) gate was set in the 7 AAD negative area. 10^4 7-AAD- cells were counted as the living population.
Note: Before staining with 7-AAD, the two additional steps of washing the cells with Fb (recommended in the guidelines) is not performed (validated in internal research).
MAIN STUDY : Activation test
In case of non-toxic concentration for the top dose used in preliminary test, the maximum concentration selected for activation test must not exceed 1000 µg/mL when the test item is dissolved or stably dispersed in Ethanol or DMSO, and 5000 µg/mL when the test item is dissolved in a saline vehicle.
In case of product cytotoxicity, the eight final test item concentrations are selected approximately according to the calculated CV75.
The range of concentrations was adjusted for activation test 2 and 3 (if necessary) depending on results obtained in previous experiments, to calculate the minimum induction threshold. Each activation test was performed on eight concentrations.
THP-1 cells (provided from American Type Culture Collection (batch 61077351)) were plated at 1*106 cells/mL/well in 24 well plates and treated for 24±0.5 hours at 37±1°C under 5±1% CO2 with selected test item concentrations. After treatment cells were washed twice with Fb.
Note: After washing, blocking the cells with Fb buffer containing 0.01% (w/v) globulin (recommended in the guidelines) was not performed due to low expression of receptors FcR by the cells THP-1.
Then cells were stained for 30 min at about 4°C with the following fluorescein isothiocyanate (FITC) conjugated monoclonal antibodies (mAbs): anti-human CD54, anti-human CD86; FITC labelled-mouse IgG1. Using the manufacturer’s recommended dilutions, cells were incubated with above mAbs at 6 µL/3*105 cells /50µL for the anti-human CD86 mAb, and 3 µL/3*105 cells /50µL for the anti-human CD54 mAb. FITC labelled-mouse IgG1 was used as an isotype control at a dilution of 3 µL/3*105 cells /50µL. Then, the cells were stained also with 7-AAD for at least 30 min at about 4°C. After washing and resuspension with Fb, the fluorescence intensities of the THP-1 cell surface markers were then analysed by flow cytometry using GUAVA (Merck Millipore, France) and InCyte software, on 10000 living cells.
Note: Before staining with 7-AAD, the cells were washed once with Fb instead of twice as recommended in the guidelines (validated in internal research).
PREPARATION OF TEST SOLUTIONS
- Solubility of the test item in solvents:
The test item was soluble in Ethanol, the highest solubilized concentration was 1000 µg/mL. Based on the solubility test, the doses range for cytotoxicity test was the following (with two fold dilution factor): from 7.81 to 1000 µg/mL.
- Vehicle control:
As the maximal dose for this test item (500 mg/mL) was obtained in the Ethanol, then, the vehicle control for all of the assays in this study was Ethanol, provided by Sigma.
- Preparation of the positive controls:
*2,4-dinitrochlorobenzene (DNCB) was prepared in DMSO and the final treatment concentration was 4 μg/mL in the plate. The DNCB was supplied by Sigma.
*Nickel sulfate (NiSO4) was prepared in PBS and the final treatment concentration was 100 μg/mL in the plate. The NiSO4 was supplied by Sigma.
- Preparation of the negative control:
The negative control was Lactic acid (LA), prepared in 0.9% NaCl and the final treatment concentration was 1000 μg/mL in the plate. The LA was supplied by Sigma.
DATA EVALUATION
- Cytotoxicity assessment :
The CV75 value, i.e. a concentration showing 75% of THP-1 cell survival (25% cytotoxicity) is calculated by log-linear interpolation using the following equation:
Log CV75 = [(75-c) x Log (b) – (75-a) x Log (d)] / (a – c)
a: minimum value of cell viability over 75%
c: maximum value of cell viability below 75%
b and d are the concentrations showing the value of cell viability a and c respectively
- Analysis of results :
Based on the geometric mean fluorescence intensity (MFI), the relative fluorescence intensity (RFI) of CD86 and CD54 for the positive control cells and test article-treated cells were calculated according to the following equation:
RFI = (MFI of test item-treated cells – MFI of test item-treated isotype control cells / MFI of vehicle control cells – MFI of vehicle isotype control cells) x100
When the cell viability was less than 50%, RFI was not exploited because of the diffuse labelling of cytoplasmic structures that are generated following cell membrane destruction.
- Prediction model used:
If two or three independent experiments, at any dose exceed the positive criteria: The RFI of CD86 ≥ 150% or the RFI of CD54 ≥ 200% of their respective vehicle control, the test item may be identified as a sensitizer. Otherwise it is identified as a non-sensitizer.
- Calculation of Effective Concentration (EC) Value :
For test articles predicted as POSITIVE, two EC values, the EC150 for CD86 and the EC200 for CD54, , i.e. the concentration at which the test item induced a RFI of 150 or 200, may be determined, are calculated as follows:
EC150 (for CD86) = Bconcentration + [(150 – BRFI) / (ARFI – BRFI) x (Aconcentration – Bconcentration)]
EC200 (for CD54) = Bconcentration + [(200 – BRFI) / (ARFI – BRFI) x (Aconcentration– Bconcentration)]
Where: A concentration is the lowest concentration in µg/mL with RFI >150 (CD86) or 200 (CD54) ; Bconcentration is the highest concentration in µg/mL with RFI < 150 (CD86) or 200 (CD54)
ARFI is the RFI at the lowest concentration with RFI >150 (CD86) or 200 (CD54)
BRFI is the RFI at the highest concentration with RFI < 150 (CD86) or 200 (CD54).
The ECs are calculated for each experiment. If three experiments are performed, the final EC150/EC200 values are then determined as the median value of the ECs calculated from the three independent runs. When only two experiments are performed or two of three independent runs meet the criteria for positivity, the highest EC150 or EC200 of the two calculated values are adopted.
- Determination of MIT (Minimum Induction Threshold):
The MIT is determined as the smallest of either EC150 or EC200.
ASSAY ACCEPTANCE CRITERIA
-In the positive control (DNCB) (performed in all activation experiments) and (NiSO4) (performed only in an activation experiment):
* RFI values of both CD86 and CD54 must be over the positive criteria (CD54 ≥ 200% and CD86 ≥ 150%).
* The cell viability must be more than 50%.
-In the negative control (LA) (performed only in an activation experiment):
* RFI values of both CD86 and CD54 must be under the positive criteria (CD54 < 200% and CD86 < 150%).
* The cell viability must be more than 50%.
-In the vehicle control (medium, 0.9% NaCl, DMSO, Ethanol etc.):
* Cell viability must be more than 90%.
* In the solvent/vehicle control, RFI values of both CD86 and CD54 must not exceed the positive criteria (CD86 ≥ 150% and CD54 ≥ 200%) compared to the medium control.
* The MFI ratio of both CD86 and CD54 to isotype control must be > 105%.
-In the test item:
* Cell viability must be more than 50% in at least four tested concentrations in each run. - Vehicle / solvent control:
- other: Ethanol
- Negative control:
- DL-Lactic acid
- Positive control:
- other: 2,4-dinitrochlorobenzene (DNCB) and Nickel sulfate (NiSO4)
Results and discussion
- Positive control results:
- Results of positive controls met the acceptance criteria defined for this method.
In vitro / in chemico
Results
- Key result
- Group:
- test chemical
- Run / experiment:
- other: Preliminary cytotoxicity test
- Parameter:
- CV75 [442D and 442E]
- Cell viability:
- >75% in all tested concentrations
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Remarks:
- Due to % cell viability>97% in all tested concentrations : non cytotoxic
- Outcome of the prediction model:
- negative [in vitro/in chemico]
- Other effects / acceptance of results:
- DEMONSTRATION OF TECHNICAL PROFICIENCY:
The test system was checked after thawing. DNCB and nickel sulphate produce a positive response of both CD86 and CD54 and lactic acid produce a negative response of both CD86 and CD54, in experiment 1 and experiment 2.
ACCEPTANCE OF RESULTS:
Test system was validated as all acceptability criteria were fulfilled:
-The cell viabilities of medium and solvent/vehicle control were higher than 90% in each independent experiment.
-For the solvent/vehicle controls, RFI values of both CD86 and CD54 did not exceed the positive criteria (CD86 RFI ≥150% and CD54 RFI ≥200%).
-For both medium and solvent/vehicle controls, the ratio of both markers CD86 and CD54 to isotype control was >105% on all occasions.
-For the positive control, RFI values were ≥150% for CD86 and ≥200% for CD54, and cell viability was >50% in each independent experiment.
-For the test article, the cell viability was more than 50% in all tested concentrations in each independent experiment.
Any other information on results incl. tables
Main test summary results
Relative Fluorescence Intensity (RFI) of CD54/86 expressions are presented in table 7.4.1.1:
Sample | Dose Level (µg/mL) | Experiment 1 | Experiment 2 | ||||
CD54 | CD86 | Cell Viability (%) | CD54 | CD86 | Cell Viability (%) | ||
Ethanol |
| 97 | 88 | 97.3 | 93 | 102 | 98.1 |
RPMI (Rowell Park Memorial Institute Medium) |
| 100 | 100 | 97.5 | 100 | 100 | 97.8 |
DMSO | - | 143 | 124 | 96.6 | 134 | 147 | 97.8 |
DNCB | 4 | 1417 | 466 | 80.4 | 1283 | 431 | 82.5 |
Test article (vehicle: 0.2% Ethanol in RPMI) | 7.81 | 90 | 101 | 97.3 | 97 | 92 | 98.2 |
15.6 | 90 | 89 | 97.8 | 85 | 97 | 98.3 | |
31.3 | 95 | 93 | 97.6 | 85 | 83 | 97.9 | |
62.5 | 88 | 101 | 97.7 | 103 | 82 | 98.1 | |
125 | 113 | 109 | 97.2 | 106 | 106 | 97.8 | |
250 | 109 | 104 | 97.0 | 106 | 94 | 97.8 | |
500 | 105 | 93 | 96.5 | 106 | 89 | 97.2 | |
1000 | 108 | 108 | 96.3 | 100 | 93 | 95.7 |
Quality control of the test system
Results (obtained in the experiment 1) are summarized in the following tables:
Table 7.4.1.2: Cell viability and ratio of both markers CD54 and CD86 to isotype control obtained for vehicles and controls
Sample | Cell viability (%) | Ratio CD54/IgG | Ratio CD86/IgG | |||
Criteria | Results | Criteria | Results | Criteria | Results | |
Ethanol (0.2%, v/v in RPMI) | >90% | 97.3 | >105 | 121 | >105 | 193 |
RPMI | >90% | 97.5 | >105 | 120 | >105 | 198 |
| >90% | 97.3 | >105 | 122 | >105 | 216 |
DMSO (0.2%, v/v in RPMI) | >90% | 96.6 | >105 | 132 | >105 | 234 |
NiSO4 | >50% | 84.5 | / | / | / | / |
DNCB | >50% | 80.4 | / | / | / | / |
LA | >50% | 97.0 | / | / | / | / |
Table 7.4.1.3: RFI values obtained for vehicles and controls
Sample | RFI | ||
Criteria | Results CD54 | Results CD86 | |
Ethanol (0.2%, v/v in RPMI) | <200 (CD54) and <150 (CD86) | 97 | 88 |
0.9% NaCl (1%, v/v in RPMI) | <200 (CD54) and <150 (CD86) | 104 | 113 |
DMSO (0.2%, v/v in RPMI) | <200 (CD54) and <150 (CD86) | 143 | 124 |
NiSO4 | ≥200 (CD54) and ≥150 (CD86) | 5613 | 316 |
DNCB | ≥200 (CD54) and ≥150 (CD86) | 1417 | 466 |
LA | <200 (CD54) and <150 (CD86) | 116 | 56 |
Results (obtained in the experiment 2) are summarized in the following tables:
Table 7.4.1.4: Cell viability and ratio of both markers CD54 and CD86 to isotype control obtained for vehicles and controls
Sample | Cell viability (%) | Ratio CD54/IgG | Ratio CD86/IgG | |||
Criteria | Results | Criteria | Results | Criteria | Results | |
Ethanol (0.2%, v/v in RPMI) | >90% | 98.1 | >105 | 123 | >105 | 212 |
RPMI | >90% | 97.8 | >105 | 124 | >105 | 205 |
| >90% | 97.8 | >105 | 134 | >105 | 265 |
DNCB | >50% | 82.5 | / | / | / | / |
Table 7.4.5: RFI values obtained for vehicles and controls
Sample | RFI | ||
Criteria | Results CD54 | Results CD86 | |
Ethanol (0.2%, v/v in RPMI) | <200 (CD54) and <150 (CD86) | 93 | 102 |
DMSO (0.2%, v/v in RPMI) | <200 (CD54) and <150 (CD86) | 134 | 147 |
DNCB | ≥200 (CD54) and ≥150 (CD86) | 1283 | 431 |
According to these results, the test system was valid for these experiments.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test article Phenylacetylene, was considered to be negative in the human Cell Line activation Test. Therefore, the test item has not to be classified as skin sensitiser according to the Regulation EC No. 1272/2008 (CLP) and to the GHS.
- Executive summary:
The study was conducted to investigate the potential of Phenylacetylene (batch N°LTWK2021-02) to activate monocytes and dendritic cells in the human monocytic leukemia cell line THP-1, by quantifying changes in the expression of cell surface markers (CD86 and CD54). The data may be used as part of an integrated approach to testing and assessment (IATA) to support the discrimination between skin sensitisers and non-sensitisers for the purpose of hazard classification and labelling.
The human Cell Line Activation Test (h-CLAT) was performed according to OECD TG 442E and in compliance with GLP.A solubility of the test item in a suitable solvent was assessed before performing the assay. The tes item was soluble in Ethanol, the highest solubilized concentration was 1000 µg/mL.
Firstly cytotoxicity profile of the test item was assessed with the 7-AAD dye. Based on the solubility test, the doses range for cytotoxicity test was the following (with two fold dilution factor): from 7.81 to 1000 µg/mL. No cytotoxicity was induced on THP-1 cells by the test item (% cell viability>75% in all tested concentrations) and no CV75 value could be determined. Under the assay conditions, no reproducible "increase" of the CD54/86 expression compared with the vehicle control was noticed, for the test item.
All acceptance criteria of the h-CLAT assay parameters were met in each experiment.
The test article Phenylacetylene (batch N°LTWK2021-02) was considered to be negative in the human Cell Line activation Test. Therefore, the test item has not to be classified as skin sensitiser according to the Regulation EC No. 1272/2008 (CLP) and to the GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.